GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jinxin Fertility Group Ltd (HKSE:01951) » Definitions » Other Operating Expense

Jinxin Fertility Group (HKSE:01951) Other Operating Expense : HK$-36 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Jinxin Fertility Group Other Operating Expense?

Jinxin Fertility Group's Other Operating Expense for the six months ended in Dec. 2023 was HK$-11 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-36 Mil.

Jinxin Fertility Group's quarterly Other Operating Expense declined from Dec. 2022 (HK$-2 Mil) to Jun. 2023 (HK$-24 Mil) but then increased from Jun. 2023 (HK$-24 Mil) to Dec. 2023 (HK$-11 Mil).

Jinxin Fertility Group's annual Other Operating Expense increased from Dec. 2021 (HK$-8 Mil) to Dec. 2022 (HK$-8 Mil) but then declined from Dec. 2022 (HK$-8 Mil) to Dec. 2023 (HK$-36 Mil).


Jinxin Fertility Group Other Operating Expense Historical Data

The historical data trend for Jinxin Fertility Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinxin Fertility Group Other Operating Expense Chart

Jinxin Fertility Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial -3.90 -9.22 -8.47 -7.81 -35.61

Jinxin Fertility Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.18 -5.86 -2.23 -24.13 -11.48

Jinxin Fertility Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinxin Fertility Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Jinxin Fertility Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinxin Fertility Group (HKSE:01951) Business Description

Traded in Other Exchanges
Address
No. 301, North Jingsha Road, Jinjiang District, Sichuan, Chengdu, CHN
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm generates its revenue from Assisted reproductive services, management services, and ancillary medical services. Geographically, it generates a majority of its revenue from the People's Republic of China.
Executives
Jinxin Fertility Investment Group Limited 2101 Beneficial owner
Hrc Investment Holding, Llc
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

Jinxin Fertility Group (HKSE:01951) Headlines

No Headlines